Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects

Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of drug and alcohol abuse Vol. 45; no. 3; pp. 276 - 284
Main Authors Dong, Huixi, Yang, Cheng, Shen, Yidong, Liu, Liang, Liu, Mengqi, Hao, Wei
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 04.05.2019
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects. Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers. Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence. Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.
AbstractList Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects. Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers. Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence. Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.
Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.BACKGROUNDRepeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.OBJECTIVESTo examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.METHODSA cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.RESULTSBoth methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.CONCLUSIONSThe combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.
Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown. To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects. A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers. Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence. The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.
Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater psychotic effect is still unknown.Objectives: To examine the effect of different levels of ketamine use on psychotic disorders and symptoms in male methamphetamine-dependent subjects.Methods: A cross-sectional, structured, and clinical interview method was used to examine the differences in DSM-IV-TR Axis I psychotic disorders and symptoms among methamphetamine-dependent subjects in three categories: 205 with no ketamine use, 38 with occasional ketamine use, and 72 with ketamine abuse or dependence from compulsory rehabilitation centers.Results: Both methamphetamine-dependent subjects with occasional ketamine use and those with ketamine abuse or dependence had a higher prevalence of psychotic disorders than those who had not used ketamine (p = 0.021; p < 0.001). Subjects who used ketamine occasionally had a higher prevalence of referential and persecutory delusions (p < 0.001; p = 0.013) and auditory hallucinations (p = 0.030), and those with ketamine abuse or dependence had a higher prevalence of referential and persecutory delusions (p = 0.005; p = 0.021), compared with those who had not used ketamine. There was no significant difference in any psychotic disorders or symptoms between subjects with occasional ketamine use and those with ketamine abuse or dependence.Conclusions: The combination of methamphetamine and ketamine was associated with greater psychotic effects than methamphetamine alone. Both occasional ketamine use and ketamine abuse or dependence were associated with increased psychotic symptoms and disorders in methamphetamine-dependent males.
Author Yang, Cheng
Liu, Mengqi
Shen, Yidong
Dong, Huixi
Liu, Liang
Hao, Wei
Author_xml – sequence: 1
  givenname: Huixi
  surname: Dong
  fullname: Dong, Huixi
  organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health
– sequence: 2
  givenname: Cheng
  surname: Yang
  fullname: Yang, Cheng
  organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health
– sequence: 3
  givenname: Yidong
  surname: Shen
  fullname: Shen, Yidong
  organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health
– sequence: 4
  givenname: Liang
  surname: Liu
  fullname: Liu, Liang
  organization: Wuxi Mental Health Center, Nanjing Medical University
– sequence: 5
  givenname: Mengqi
  surname: Liu
  fullname: Liu, Mengqi
  organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health
– sequence: 6
  givenname: Wei
  surname: Hao
  fullname: Hao, Wei
  email: weihao57@csu.edu.cn
  organization: Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, Central South University, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30640573$$D View this record in MEDLINE/PubMed
BookMark eNqFkUuP1DAQhC20iJ1d-AkgS1w4kMHP2BEX0Gp5SCtxgbPlJG3GQ2wH2xGaf09GM3PZA5y6D19Vl7pu0FVMERB6ScmWEk3eEdJJ1nVkywjVWyplp0X3BG0o6VTT6Y5eoc2RaY7QNbopZU_IiirxDF1z0goiFd-gn_fOwVALTg7_gmqDj4CXAjhFPJfDsEvVD3j0JeURcsE2jrgcwlxTKNhHHOwEb3GAurNh3p0NmhFmiCPEisvS74_-z9FTZ6cCL87zFv34dP_97kvz8O3z17uPD80gGKmNplK73rYgWteveUnb9W5QoARXLbhRCSc5VevCBR97RqHVwJjWAMAElfwWvTn5zjn9XqBUE3wZYJpshLQUw6jquGyZUCv6-hG6T0uOazrDGOGScd3SlXp1ppY-wGjm7IPNB3N54Qq8PwFDTqVkcGbw1VafYs3WT4YScyzMXAozx8LMubBVLR-pLwf-p_tw0vnoUg72T8rTaKo9TCm7bOPgi-H_tvgLw9GsNw
CitedBy_id crossref_primary_10_2174_1570159X19666210215121428
Cites_doi 10.1016/j.joca.2016.01.008
10.1126/science.2563176
10.1016/j.drugalcdep.2017.01.021
10.1097/00000542-199704000-00021
10.1196/annals.1316.036
10.1016/j.taap.2007.10.017
10.1093/schbul/sbs075
10.1016/j.jpsychires.2014.02.010
10.1016/j.annepidem.2013.07.012
10.1186/s12888-017-1346-7
10.1016/S0140-6736(09)60660-7
10.1016/j.psychres.2014.11.077
10.15288/jsad.2012.73.938
10.1016/j.drugalcdep.2013.12.011
10.1097/00005053-199908000-00001
10.1196/annals.1316.035
10.1016/S0006-3223(00)00976-8
10.1177/0269881113512909
10.1016/j.psychres.2016.01.023
10.3389/fpubh.2013.00061
10.1002/syn.890190205
10.1016/j.addbeh.2012.06.024
10.1016/j.brainres.2014.10.044
10.1016/j.jpainsymman.2011.01.001
10.1016/S0376-8716(02)00243-0
10.1001/archpsyc.62.9.985
ContentType Journal Article
Copyright 2018 Taylor & Francis Group, LLC. 2018
2018 Taylor & Francis Group, LLC.
Copyright_xml – notice: 2018 Taylor & Francis Group, LLC. 2018
– notice: 2018 Taylor & Francis Group, LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7U3
BHHNA
K7.
K9.
7X8
DOI 10.1080/00952990.2018.1559849
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
Social Services Abstracts
Sociological Abstracts
ProQuest Criminal Justice (Alumni)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
ProQuest Criminal Justice (Alumni)
Social Services Abstracts
Applied Social Sciences Index and Abstracts (ASSIA)
Sociological Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Social Welfare & Social Work
EISSN 1097-9891
EndPage 284
ExternalDocumentID 30640573
10_1080_00952990_2018_1559849
1559849
Genre Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Key R&D Program of China
  grantid: 2017YFC3140401
– fundername: National 973 Program
  grantid: 2015CB553500
GroupedDBID ---
00X
03L
0BK
0R~
123
23M
2QV
36B
4.4
5RE
6J9
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABIVO
ABLCE
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFO
ACGOD
ACHQT
ACIEZ
ACKLR
ACUHS
ACVOX
ADCVX
ADRBQ
ADXPE
ADZJE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AHMBA
AIAGR
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
ASUFR
BABNJ
BLEHA
BOHLJ
CCCUG
COF
CS3
DKSSO
DXH
EAP
EAS
EBC
EBD
EBS
EHN
EJD
EMB
EMK
EMOBN
EPL
EPS
EPT
ESI
ESO
ESX
F5P
FEDTE
H13
HZ~
KRBQP
KSSTO
KUULJ
KWAYT
KYCEM
L7B
LJTGL
M4Z
O9-
P2P
PQQKQ
Q~Q
RNANH
RVRKI
RWL
SV3
TAE
TBQAZ
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
U5U
V1S
WH7
X6Y
XSW
~1N
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
TDBHL
.GJ
34G
39C
53G
5VS
AADGC
AALIY
AAPXX
AAQQT
ABGNL
ACKFH
ACWGZ
ADPSL
ADVEQ
AEIQB
AELXL
AETHL
AEXKJ
AFFNX
AFLJA
AGXXK
AI.
AIKPT
APIUT
AWYRJ
B0M
BTKSN
C1A
CAG
CGR
COGVJ
CUY
CVF
ECM
EIF
HAMGP
HVGLF
H~9
LSO
M44
NPM
VH1
VQP
YYQ
ZGI
ZXP
7QJ
7U3
BHHNA
K7.
K9.
TASJS
7X8
ID FETCH-LOGICAL-c420t-8158fba6e46fb000069bfc7e74376efd74f5317fd7343db21e68e2288eee24153
ISSN 0095-2990
1097-9891
IngestDate Fri Jul 11 00:09:34 EDT 2025
Thu Aug 07 15:21:52 EDT 2025
Thu Apr 03 06:59:36 EDT 2025
Tue Jul 01 01:49:29 EDT 2025
Thu Apr 24 22:56:11 EDT 2025
Wed Dec 25 09:08:09 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords DSM-IV
psychotic symptoms
psychotic disorders
ketamine
methamphetamine
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-8158fba6e46fb000069bfc7e74376efd74f5317fd7343db21e68e2288eee24153
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 30640573
PQID 2203523861
PQPubID 48364
PageCount 9
ParticipantIDs proquest_journals_2203523861
pubmed_primary_30640573
informaworld_taylorfrancis_310_1080_00952990_2018_1559849
proquest_miscellaneous_2179356247
crossref_citationtrail_10_1080_00952990_2018_1559849
crossref_primary_10_1080_00952990_2018_1559849
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-04
PublicationDateYYYYMMDD 2019-05-04
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-04
  day: 04
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle The American journal of drug and alcohol abuse
PublicationTitleAlternate Am J Drug Alcohol Abuse
PublicationYear 2019
Publisher Taylor & Francis
Taylor & Francis Ltd
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
References CIT0030
CIT0010
CIT0012
CIT0011
CIT0014
CIT0013
CIT0016
CIT0015
CIT0018
CIT0019
CIT0021
CIT0020
World Drug Report (CIT0001) 2016
CIT0023
CIT0022
First M (CIT0017) 2003
Annual Report on Drug Control in China (CIT0003) 2017
CIT0025
CIT0024
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
Annual Report on Drug Control in China (CIT0002) 2004
CIT0009
CIT0008
References_xml – ident: CIT0020
  doi: 10.1016/j.joca.2016.01.008
– ident: CIT0030
  doi: 10.1126/science.2563176
– ident: CIT0015
  doi: 10.1016/j.drugalcdep.2017.01.021
– volume-title: National Narcotic Control Commission (NNCC)
  year: 2017
  ident: CIT0003
– ident: CIT0026
  doi: 10.1097/00000542-199704000-00021
– ident: CIT0025
  doi: 10.1196/annals.1316.036
– ident: CIT0028
  doi: 10.1016/j.taap.2007.10.017
– ident: CIT0006
  doi: 10.1093/schbul/sbs075
– ident: CIT0014
  doi: 10.1016/j.jpsychires.2014.02.010
– ident: CIT0009
  doi: 10.1016/j.annepidem.2013.07.012
– volume-title: Structured clinical interview for DSM-IV-TR axis I disorders
  year: 2003
  ident: CIT0017
– volume-title: United nations office on drugs and crime. United Nations publication, Sales No.  E.16.XI.7
  year: 2016
  ident: CIT0001
– ident: CIT0010
  doi: 10.1186/s12888-017-1346-7
– ident: CIT0018
  doi: 10.1016/S0140-6736(09)60660-7
– ident: CIT0004
  doi: 10.1016/j.psychres.2014.11.077
– ident: CIT0016
  doi: 10.15288/jsad.2012.73.938
– ident: CIT0011
  doi: 10.1016/j.drugalcdep.2013.12.011
– ident: CIT0019
  doi: 10.1097/00005053-199908000-00001
– ident: CIT0023
  doi: 10.1196/annals.1316.035
– volume-title: National Narcotic Control Commission (NNCC)
  year: 2004
  ident: CIT0002
– ident: CIT0022
  doi: 10.1016/S0006-3223(00)00976-8
– ident: CIT0005
  doi: 10.1177/0269881113512909
– ident: CIT0007
  doi: 10.1016/j.psychres.2016.01.023
– ident: CIT0012
  doi: 10.3389/fpubh.2013.00061
– ident: CIT0029
  doi: 10.1002/syn.890190205
– ident: CIT0013
  doi: 10.1016/j.addbeh.2012.06.024
– ident: CIT0024
  doi: 10.1016/j.brainres.2014.10.044
– ident: CIT0027
  doi: 10.1016/j.jpainsymman.2011.01.001
– ident: CIT0008
  doi: 10.1016/S0376-8716(02)00243-0
– ident: CIT0021
  doi: 10.1001/archpsyc.62.9.985
SSID ssj0001874
Score 2.213581
Snippet Background: Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a...
Repeated and extensive methamphetamine or ketamine use may cause psychotic symptoms. Whether the chronic and combined use of these substances has a greater...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 276
SubjectTerms Adult
Amphetamine-Related Disorders
Auditory hallucinations
Between-subjects design
Central Nervous System Stimulants - administration & dosage
Central Nervous System Stimulants - adverse effects
Clinical interviews
Delusions
Drug abuse
Drug addiction
DSM-IV
Hallucinations
Humans
Ketamine
Ketamine - administration & dosage
Ketamine - adverse effects
Male
Males
Men
Methamphetamine
Methamphetamine - administration & dosage
Methamphetamine - adverse effects
Persecutory ideation
Psychoses, Substance-Induced - etiology
Psychosis
psychotic disorders
Psychotic symptoms
Rehabilitation
Substance abuse
Symptoms
Title Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects
URI https://www.tandfonline.com/doi/abs/10.1080/00952990.2018.1559849
https://www.ncbi.nlm.nih.gov/pubmed/30640573
https://www.proquest.com/docview/2203523861
https://www.proquest.com/docview/2179356247
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZK98IF8aZQkJEQlyVVk7iOc9xHqwpVyyUV5RTZqc1Gu01WbSIev55x7DwqutqFSxS5dZL2-zIejz3fIPSBESFdrqgTMsIdAlNmhzEuHOCK54dJMlbrSu3zgs6X5PNqsur1fnSzSwoxSn4fzCv5H1ShDXDVWbL_gGxzUWiAc8AXjoAwHO-F8bTdjHElC77RHmOpg_NZnV2VJnoJptLXNGLMu1-bmyLfVLtgN3Yvsa4izQFVewmnLoxbHO9KoeM0u64LG7W5KFlXeGK9LU26IzdVd4-5KNuVn3O79Xdepj_TxtTYYPXZpbQDqBGLrCzht3Sdt62LtDQhBG7bbKRCJ0dNHFNb2BrXcRgAJ0x1rpE80GYtshGYtMzzu-bV1Ir5y-zX-yTDiR5d9YY9NtLrrczIoe7LbF98iWfLxSKOpqvoATryYH7h9dHRyen56awZxHWpwmqh3D5enfylZdkP3WbPrdkTvb196lK5MNFj9MjOPfCJIdIT1JPZUzQ0Cdr4q7xWfCvxR1w35NurZ-i75RjOFa45hgFXnGe44RhuOIaBALjmGE4zrDn2Cd_KMFwz7DlazqbR2dyxxTmchHjjwmHuhCnBqSRUVTMNGgqVBBI80oBKtQ6IAvMewIlP_LXwXEmZ9DzGpJTaa_RfoH6WZ_IVwjDEsnCsFA1VSAjhnHrgicvAJYoKwYIBIvV_GydWuV4XULmO3Ubg1kASa0hiC8kAjZpuN0a65a4OYRe4uKhiZsoUuIn9O_oOa5Rj--rtYs_TasM-o-4AvW8-BvutF-V4JvMSvqNHSJiEEPiZLw07mqfV0QEtWPr6Hr3foIftOzdE_WJbyrfgLxfineX2H5dDvGQ
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+ketamine+use+on+psychotic+disorders+and+symptoms+in+male%2C+methamphetamine-dependent+subjects&rft.jtitle=The+American+journal+of+drug+and+alcohol+abuse&rft.au=Dong%2C+Huixi&rft.au=Yang%2C+Cheng&rft.au=Shen%2C+Yidong&rft.au=Liu%2C+Liang&rft.date=2019-05-04&rft.issn=1097-9891&rft.eissn=1097-9891&rft.volume=45&rft.issue=3&rft.spage=276&rft_id=info:doi/10.1080%2F00952990.2018.1559849&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-2990&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-2990&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-2990&client=summon